Core Viewpoint - A class action securities lawsuit has been filed against Cardlytics, Inc. for alleged securities fraud affecting investors between March 14, 2024, and August 7, 2024 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Cardlytics made false statements regarding consumer engagement and its ability to increase billings, leading to a significant risk of revenue growth slowing or declining [2]. - It is alleged that changes to the Ads Decision Engine resulted in "under-delivery" of budgets and customer billing estimates, which misled investors about the company's business prospects [2]. Group 2: Investor Information - Investors who suffered losses during the specified timeframe have until March 25, 2025, to request to be appointed as lead plaintiff, although participation in any recovery does not require this [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [4].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Cardlytics, Inc. regarding a class action lawsuit due to alleged misleading statements and omissions during a specified class period [1]. Group 1: Allegations - The complaint alleges that during the class period from March 14, 2024, to August 7, 2024, Cardlytics made materially false and/or misleading statements [1]. - Specific allegations include that increasing consumer engagement led to higher consumer incentives, but the company could not increase its billings accordingly, posing a risk of revenue growth slowing or declining [1]. - Changes to the Ads Decision Engine resulted in increased consumer engagement but also led to "under-delivery" of budgets and customer billing estimates, making the company's positive statements misleading [1]. Group 2: Class Action Details - Shareholders who purchased shares of CDLX during the class period are encouraged to register for the class action, with a deadline of March 25, 2025, to seek lead plaintiff status [2]. - Once registered, shareholders will be enrolled in a portfolio monitoring software to receive updates throughout the case lifecycle [2]. - Participation in the case incurs no cost or obligation for shareholders [2]. Group 3: Law Firm's Mission - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit, fraud, and illegal business practices [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions that inflated stock prices [3].

Core Viewpoint - Cardlytics is facing a class-action lawsuit for allegedly misleading investors about its growth prospects, with claims that the company failed to disclose critical information regarding its financial performance and business operations [1][3][4]. Group 1: Lawsuit Details - The class period for the lawsuit is from March 14, 2024, to August 7, 2024, with a lead plaintiff deadline set for March 25, 2025 [2]. - The lawsuit, filed in the Northern District of Georgia, accuses Cardlytics and certain executives of violating the Securities Exchange Act of 1934 [2]. - Plaintiffs allege that Cardlytics made false and misleading statements regarding the impact of increased consumer engagement on financial performance, claiming that while engagement rose, it did not translate into corresponding growth in billings [4]. Group 2: Financial Performance and Stock Impact - Following the company's disclosures, two significant stock drops occurred: on May 8, 2024, after reporting only an 8% year-over-year revenue increase despite a 12% increase in billings, leading to a stock price drop of over 36% [6]. - On August 7, 2024, Cardlytics reported a 9% year-over-year decline in revenue to $69.6 million and a 3% decrease in adjusted contribution to $36.4 million, resulting in a stock price plummet of over 57% after the announcement of the CEO's resignation [7].

Core Viewpoint - A class action securities lawsuit has been filed against Cardlytics, Inc. for alleged securities fraud affecting investors between March 14, 2024, and August 7, 2024 [1][2]. Group 1: Allegations and Claims - The lawsuit claims that the defendants made false statements regarding consumer engagement and its impact on revenue, indicating that increased consumer engagement led to higher consumer incentives but did not result in proportional billings [2]. - It is alleged that there was a significant risk of slowing or declining revenue growth due to the inability to increase billings in line with consumer engagement [2]. - The changes to the Ads Decision Engine, which were intended to boost consumer engagement, resulted in "under-delivery" of budgets and customer billing estimates, misleading investors about the company's operational health [2]. Group 2: Legal Process and Participation - Investors who suffered losses during the specified timeframe have until March 25, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this role [3]. - Class members may be entitled to compensation without incurring any out-of-pocket costs or fees, emphasizing that there is no financial obligation to participate [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years and consistently ranking among the top securities litigation firms in the U.S. [4].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Cardlytics, Inc. regarding a class action lawsuit due to alleged misleading statements and omissions during a specified class period [1]. Group 1: Allegations - The complaint alleges that during the class period from March 14, 2024, to August 7, 2024, Cardlytics made materially false and/or misleading statements [1]. - Specific allegations include that increasing consumer engagement led to higher consumer incentives, but the company could not increase its billings accordingly, posing a risk of revenue growth slowing or declining [1]. - Changes to the Ads Decision Engine resulted in increased consumer engagement but also led to "under-delivery" of budgets and customer billing estimates, making the company's positive statements misleading [1]. Group 2: Class Action Details - Shareholders who purchased shares of CDLX during the class period are encouraged to register for the class action, with a deadline of March 25, 2025, to seek lead plaintiff status [2]. - Once registered, shareholders will receive updates through a portfolio monitoring software throughout the case lifecycle [2]. - Participation in the case incurs no cost or obligation for shareholders [2]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit, fraud, and illegal business practices [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions [3].

Core Viewpoint - A class action securities lawsuit has been filed against Cardlytics, Inc. for alleged securities fraud affecting investors between March 14, 2024, and August 7, 2024 [1] Group 1: Allegations of Fraud - The lawsuit claims that Cardlytics made false statements regarding consumer engagement and its ability to increase billings in line with that engagement [2] - It is alleged that there was a significant risk of slowing or declining revenue growth due to these misleading statements [2] - The changes to the Ads Decision Engine, which were supposed to enhance consumer engagement, resulted in "under-delivery" of budgets and customer billing estimates [2] Group 2: Legal Process and Participation - Investors who suffered losses during the specified timeframe have until March 25, 2025, to request to be appointed as lead plaintiff [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees [3] Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [4]

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Cardlytics, Inc. due to allegations of violations of federal securities laws, encouraging affected investors to come forward [2][4]. Group 1: Legal Investigation and Claims - The law firm is urging investors who suffered losses exceeding $50,000 in Cardlytics between March 14, 2024, and August 7, 2024, to discuss their legal options [1]. - A federal securities class action has been filed against Cardlytics, with a deadline of March 25, 2025, for investors to seek the role of lead plaintiff [2][7]. - The firm has a history of recovering hundreds of millions of dollars for investors since its establishment in 1995 [3]. Group 2: Allegations Against Cardlytics - The complaint alleges that Cardlytics and its executives made false or misleading statements and failed to disclose critical information regarding consumer engagement and revenue growth [4]. - Specific allegations include the inability to increase billings in line with consumer engagement, leading to a significant risk of revenue growth slowing or declining [4]. Group 3: Financial Performance and Stock Impact - On May 8, 2024, Cardlytics reported a revenue increase of only 8% year-over-year, despite a 12% increase in billings, attributed to a 20.2% rise in consumer incentives, resulting in a stock price drop of $5.33 (36.5%) [5]. - Following the release of second-quarter 2024 results on August 7, 2024, which showed a 9% year-over-year revenue decrease to $69.6 million, the stock price fell by $3.94 (57.1%) [6].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Cardlytics, Inc. regarding a class action lawsuit due to alleged misleading statements and omissions made by the company during a specified class period [1]. Group 1: Allegations - The complaint alleges that during the class period from March 14, 2024, to August 7, 2024, Cardlytics made materially false and misleading statements [1]. - Key allegations include that increasing consumer engagement led to higher consumer incentives, but the company could not increase its billings accordingly, posing a risk of slowed or declining revenue growth [1]. - It is also claimed that changes to the Ads Decision Engine resulted in "under-delivery" of budgets and customer billing estimates, further misleading investors about the company's business prospects [1]. Group 2: Class Action Details - Shareholders who purchased shares of Cardlytics during the class period are encouraged to register for the class action, with a deadline set for March 25, 2025 [2]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the status of the case [2]. - There is no cost or obligation for shareholders to participate in this class action [2]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors affected by deceit and illegal business practices [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions [3].

Core Viewpoint - Robbins LLP has initiated a class action lawsuit on behalf of investors who acquired Cardlytics, Inc. (NASDAQ: CDLX) securities between March 14, 2024, and August 7, 2024, due to allegations of misleading information regarding the company's business prospects [1][2]. Allegations - The complaint alleges that during the class period, Cardlytics failed to disclose several critical factors: - Increasing consumer engagement led to higher consumer incentives [2] - The company was unable to increase its billings in line with the increased consumer engagement [2] - There was a significant risk that revenue growth would slow or decline as a result [2] - Changes to the Ad Decision Engine, which increased consumer engagement, resulted in "underdelivery" of budgets and customer billing estimates [2] Financial Performance - On August 7, 2024, Cardlytics reported its Q2 2024 financial results, showing a 9% year-over-year revenue decrease to $69.6 million and a 3% decline in adjusted contribution to $36.4 million [3] - Following the announcement, the company's stock price dropped by $3.94, or 57.1%, closing at $2.96 per share on August 8, 2024 [3] Class Action Participation - Shareholders interested in serving as lead plaintiffs must file necessary documents with the court by March 25, 2025 [4] - Participation in the case is not required to be eligible for recovery, and shareholders can choose to remain absent class members [4]

Core Viewpoint - A class action securities lawsuit has been filed against Cardlytics, Inc. for alleged securities fraud affecting investors between March 14, 2024, and August 7, 2024 [1][2] Group 1: Lawsuit Details - The lawsuit claims that Cardlytics made false statements regarding consumer engagement and its ability to increase billings, leading to a significant risk of revenue growth slowing or declining [2] - Allegations include that changes to the Ads Decision Engine resulted in "under-delivery" of budgets and customer billing estimates, which misled investors about the company's business prospects [2] Group 2: Investor Information - Investors who suffered losses during the specified timeframe have until March 25, 2025, to request to be appointed as lead plaintiff, although participation in any recovery does not require this [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees [3] Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [4]